CINP (Collegium Internationale Neuro-Psychopharmacologicum) is the world’s only truly global organisation dedicated to neuropsychopharmacology. It is a membership organisation with widespread support from all over the world. Its mission is to encourage and promote the international scientific study, teaching and application of neuropsychopharmacology. It also provides consultation for the better evaluation of all aspects of development and usage of neuropsychiatric drugs, including the biochemistry, pharmacology, safety and therapeutic efficacy. Through these activities it seeks to improve and advance research activities that are intended to lead to improved patient care.

CINP was established in 1957 in Zurich and had its first international congress in Rome in 1958. Since then virtually all the leading researchers in psychopharmacology have attended the meetings and been involved in the organisation. Names such as Delay, Deniker, Lehmann, Hippius, Janssen, Coppen and Carlsson are a very important part of the history of psychopharmacology and of CINP as well. The most exciting and original science in this field has been associated with CINP in the past and it is the declared intention of the current President, Prof. Torgny H. Svensson, that it will be part of CINP now as well as in the future.

CINP is a genuinely international organisation. Its major congresses have taken place on all continents. Furthermore it has regional groups which are active all over the world. These regional groups organise regional meetings, workshops and other educational activities and help generally support psychopharmacology in their regions.

CINP has an official journal, the International Journal of Neuro-Psychopharmacology, which was launched with Cambridge University Pres. This has become one of the essential journals in our field of research and it continues to grow in both size and importance. Members of the CINP receive access to the journal as a benefit of membership.